New Medicare Payment Policy on Drug Shortages

This Viewpoint describes the Centers for Medicare & Medicaid Services’ new payment policy to establish and maintain buffer supplies of designated essential medicines and suggests additional reforms to improve this policy.

Corresponding Author: Thomas J. Hwang, MD, 1620 Tremont St, Ste 3030, Boston, MA 02120 (thomas_hwang@dfci.harvard.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.